Spots Global Cancer Trial Database for cancer of the breast
Every month we try and update this database with for cancer of the breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | NCT05191004 | Advanced Breast... Metastatic Brea... Breast Cancer Breast Carcinom... Cancer of the B... Cancer of Breas... Malignant Tumor... Breast Tumor | NUV-422 Fulvestrant | 18 Years - | Nuvation Bio Inc. | |
| CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) | NCT02580448 | Cancer of the B... Breast Cancer Advanced Breast... Metastatic Brea... Male Breast Can... Triple Negative... ER+ Breast Canc... | Seviteronel | 18 Years - | Innocrin Pharmaceutical | |
| Shave Margins in Breast Conservation Therapy | NCT02462200 | Breast Cancer Cancer of Breas... Cancer of the B... | Breast-conservi... Cavity shave ma... BREAST-Q Questi... 3-D breast imag... Indocyanine gre... Intraoperative ... Peripheral bloo... | 18 Years - 85 Years | Washington University School of Medicine | |
| Pre- Versus Postoperative Accelerated Partial Breast Irradiation | NCT02913729 | Breast Cancer Cancer of the B... Neoplasms, Brea... | partial breast ... | 51 Years - | The Netherlands Cancer Institute | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing | NCT04968964 | Breast Cancer Cancer of the B... | DiviTum® TKa as... Study Care Plan... | 18 Years - | Washington University School of Medicine | |
| A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer | NCT01272141 | Breast Neoplasm... Breast Cancer Cancer of the B... | Lapatinib and E... | 18 Years - | Emory University | |
| COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients | NCT05972343 | Breast Cancer Cancer of the B... | Cryoablation | 18 Years - | Washington University School of Medicine | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment | NCT01596530 | Breast Neoplasm | Drug-AZD8931 Drug-Placebo | 18 Years - | AstraZeneca | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing | NCT04968964 | Breast Cancer Cancer of the B... | DiviTum® TKa as... Study Care Plan... | 18 Years - | Washington University School of Medicine | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | NCT02316795 | Breast Cancer Cancer of Breas... Cancer of the B... Melanoma Malignant Melan... | Sentinel lymph ... Goggle-based de... Indocynanine Gr... | 18 Years - | Washington University School of Medicine | |
| Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer | NCT01271738 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Human Mammary C... Neoplasms, Brea... | Remove tumor on... Removal of tumo... | 18 Years - | Emory University | |
| A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer | NCT01265927 | Breast Neoplasm... | GRN163L in comb... | 18 Years - | Indiana University | |
| Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer | NCT00128362 | Cancer of the B... | Radio-guided se... Axillary sampli... | 18 Years - 70 Years | Tata Memorial Hospital | |
| Primary Progesterone Therapy for Operable Breast Cancer | NCT00123669 | Breast Neoplasm... | 500 mg of depot... | 18 Years - 75 Years | Tata Memorial Hospital | |
| Bright Light on Fatigue in Women Being Treated for Breast Cancer | NCT02658708 | Breast Neoplasm... Breast Cancer Cancer of Breas... Cancer of the B... | Bright blue-gre... Dim red light u... European Organi... Epworth Sleepin... Pittsburgh Slee... Patient-Reporte... Patient-Reporte... Digital foot ca... Polysomnography... Horne-Ostberg M... Daily Fatigue a... | 21 Years - | Washington University School of Medicine | |
| Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | NCT00386087 | Breast Neoplasm... | Enzastaurin Hyd... | 18 Years - | Eli Lilly and Company | |
| Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | NCT00217815 | Cancer of the B... | Mycograb, Docet... | 18 Years - 70 Years | NeuTec Pharma | |
| ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer | NCT02632071 | Metastatic Brea... Breast Carcinom... | ACY-1215 Nab-paclitaxel | 18 Years - | Columbia University | |
| COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients | NCT05972343 | Breast Cancer Cancer of the B... | Cryoablation | 18 Years - | Washington University School of Medicine | |
| A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer | NCT01272141 | Breast Neoplasm... Breast Cancer Cancer of the B... | Lapatinib and E... | 18 Years - | Emory University | |
| Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | NCT01498588 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of the B... Neoplasms, Brea... Tumors, Breast | Eribulin Doxorubicin Cyclophosphamid... Pegfilgrastim | 18 Years - | Emory University | |
| Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial) | NCT05716542 | Breast Cancer Cancer of the B... | Physical Activi... | 18 Years - | Washington University School of Medicine | |
| Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer | NCT00983684 | Invasive Breast... Breast Cancer | Intrabeam Post-operative ... | 45 Years - | University College, London | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients | NCT00080197 | Breast Neoplasm... Metastases | E7070 | 18 Years - | Eisai Inc. | |
| Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | NCT00832338 | Breast Neoplasm... Breast Cancer Cancer of the B... | Docetaxel with ... Dexamethasone | 18 Years - | Emory University | |
| Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy | NCT02595372 | Cancer of the B... | Omeprazole | 18 Years - | Indiana University | |
| Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | NCT00661531 | Breast Cancer Cancer of the B... Neoplasms, Brea... | Estrace Anastrozole | 18 Years - | Georgetown University | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | NCT00426530 | Breast Neoplasm... Neoplasm Metast... | everolimus (RAD... | 18 Years - | Novartis | |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment | NCT02891681 | Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Malignant Neopl... | Optical Tomogra... | 18 Years - | Washington University School of Medicine | |
| Axillary Reverse Mapping | NCT00572481 | Cancer of the B... | Axillary Revers... | 18 Years - | University of Arkansas | |
| Axillary Reverse Mapping | NCT00572481 | Cancer of the B... | Axillary Revers... | 18 Years - | University of Arkansas | |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC | NCT05191004 | Advanced Breast... Metastatic Brea... Breast Cancer Breast Carcinom... Cancer of the B... Cancer of Breas... Malignant Tumor... Breast Tumor | NUV-422 Fulvestrant | 18 Years - | Nuvation Bio Inc. | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation | NCT00193778 | Cancer of the B... | Surgery for bre... No Loco-regiona... | 21 Years - 65 Years | Tata Memorial Hospital | |
| Single Dose Partial Breast Radiotherapy | NCT00944528 | Breast Cancer | Radiosurgery | 55 Years - 80 Years | Duke University | |
| Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer | NCT02820961 | Breast Cancer Estrogen Recept... | entinostat exemestane | 18 Years - 85 Years | Syndax Pharmaceuticals | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | NCT00063570 | Breast Cancer Breast Neoplasm... | Pemetrexed Gemcitabine Gemcitabine Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Pre- Versus Postoperative Accelerated Partial Breast Irradiation | NCT02913729 | Breast Cancer Cancer of the B... Neoplasms, Brea... | partial breast ... | 51 Years - | The Netherlands Cancer Institute | |
| Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects | NCT02302196 | Cancer of the B... Anomaly of Brea... | Autologous Fat ... Control Arm | 18 Years - | Kaiser Permanente | |
| CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study | NCT00412412 | Breast Cancer | CNF2024 CNF2024 + trast... | 18 Years - | Biogen | |
| Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer | NCT00530868 | Breast Cancer Cancer of the B... Breast Neoplasm | Letrozole (Fema... Letrozole; Avas... | 19 Years - | University of Alabama at Birmingham | |
| Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | NCT00426556 | Metastatic Brea... | Everolimus Trastuzumab Paclitaxel | 18 Years - | Novartis | |
| Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | NCT02316795 | Breast Cancer Cancer of Breas... Cancer of the B... Melanoma Malignant Melan... | Sentinel lymph ... Goggle-based de... Indocynanine Gr... | 18 Years - | Washington University School of Medicine | |
| Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer | NCT00817362 | Breast Cancer HER2 Positive B... Metastatic Brea... Cancer of the B... | IPI-504 Trastuzumab | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer | NCT01766297 | Breast Cancer Breast Neoplasm Breast Tumor Cancer of the B... | Proton Radiothe... | 50 Years - | Proton Collaborative Group | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects | NCT02302196 | Cancer of the B... Anomaly of Brea... | Autologous Fat ... Control Arm | 18 Years - | Kaiser Permanente | |
| Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer | NCT01271738 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Human Mammary C... Neoplasms, Brea... | Remove tumor on... Removal of tumo... | 18 Years - | Emory University | |
| Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer | NCT02632045 | Metastatic Brea... Breast Carcinom... | LEE-011 Fulvestrant Placebo | 18 Years - | Columbia University | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| Proton Radiation for Stage II/III Breast Cancer | NCT01758445 | Breast Cancer Breast Neoplasm Breast Tumor Cancer of the B... | Proton Radiothe... | 18 Years - | Proton Collaborative Group | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Proton Radiation for Stage II/III Breast Cancer | NCT01758445 | Breast Cancer Breast Neoplasm Breast Tumor Cancer of the B... | Proton Radiothe... | 18 Years - | Proton Collaborative Group | |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment | NCT02891681 | Breast Cancer Breast Tumors Cancer of Breas... Cancer of the B... Malignant Neopl... | Optical Tomogra... | 18 Years - | Washington University School of Medicine | |
| Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | NCT00386087 | Breast Neoplasm... | Enzastaurin Hyd... | 18 Years - | Eli Lilly and Company | |
| A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | NCT00191373 | Breast Neoplasm... Cancer of the B... Breast Cancer | Gemcitabine Trastuzumab | 18 Years - | Eli Lilly and Company | |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | NCT00063570 | Breast Cancer Breast Neoplasm... | Pemetrexed Gemcitabine Gemcitabine Pemetrexed | 18 Years - | Eli Lilly and Company | |
| Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer | NCT00817362 | Breast Cancer HER2 Positive B... Metastatic Brea... Cancer of the B... | IPI-504 Trastuzumab | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | NCT00832338 | Breast Neoplasm... Breast Cancer Cancer of the B... | Docetaxel with ... Dexamethasone | 18 Years - | Emory University | |
| Pre- Versus Postoperative Accelerated Partial Breast Irradiation | NCT02913729 | Breast Cancer Cancer of the B... Neoplasms, Brea... | partial breast ... | 51 Years - | The Netherlands Cancer Institute | |
| Axillary Reverse Mapping | NCT00572481 | Cancer of the B... | Axillary Revers... | 18 Years - | University of Arkansas | |
| Real-time Intraoperative Breast Cancer Visualization for Margin Assessment | NCT02807597 | Breast Cancer Cancer of the B... | LS301 Cancer Vision G... Surgery | 18 Years - | University of Texas Southwestern Medical Center | |
| Axillary Reverse Mapping | NCT00572481 | Cancer of the B... | Axillary Revers... | 18 Years - | University of Arkansas | |
| Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) | NCT01881230 | Breast Tumor Breast Cancer Cancer of the B... Estrogen Recept... HER2- Negative ... Progesterone Re... Recurrent Breas... Stage IV Breast... Triple-negative... Triple-negative... Metastatic Brea... | nab-Paclitaxel Carboplatin Gemcitabine | 18 Years - | Celgene | |
| A Phase III Trial For Patients With Metastatic Breast Cancer | NCT00191152 | Breast Cancer Breast Neoplasm... Cancer of the B... | gemcitabine docetaxel capecitabine | 18 Years - | Eli Lilly and Company | |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer | NCT00065325 | Locally Advance... Metastatic Brea... | Fulvestrant Exemestane | 32 Years - 91 Years | AstraZeneca | |
| Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy | NCT02595372 | Cancer of the B... | Omeprazole | 18 Years - | Indiana University | |
| A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer | NCT00320541 | Breast Cancer | gemcitabine paclitaxel bevacizumab | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
